TAC1 and central nervous system cancer: The resulting 211At‐labeled substance P derivative ([211At]24‐Rh‐At) was stable in PBS and cerebrospinal fluid, as well as demonstrated superior efficacy in treating human glioma T98G cells, compared to free [211At]At− at activity concentrations as low as 75 kBq/mL [191].